Diet beverages and the risk of obesity, diabetes, and cardiovascular disease: a review of the evidence

被引:68
|
作者
Pereira, Mark A. [1 ]
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA
关键词
beverages; diet; epidemiology; obesity; SUGAR-SWEETENED BEVERAGES; FOOD-INTAKE; METABOLIC SYNDROME; BODY-WEIGHT; CONSUMPTION; ADOLESCENTS; ADULTS; PATTERNS; CHILDREN; TRIAL;
D O I
10.1111/nure.12038
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
"Diet beverage" is a common term used to describe beverages that are sweetened with non-nutritive or artificial sweeteners (ASBs). Marketing strategies often imply that consuming these beverages holds promise for weight control or weight loss. The objective of the present review is to provide a synthesis of the literature on the effects of ASBs on body weight, cardiovascular disease, and type 2 diabetes. Consumption of diet beverages is much lower than that of sugar-sweetened beverages (SSBs), and people trying to lose weight report the highest levels of ASB consumption. To date, prospective observational studies have revealed mixed results, and it appears that reverse causality is a particular problem, since individuals who are at higher risk for weight gain may choose to consume ASBs in an attempt to control their weight or reduce disease risk. As for experimental studies, the evidence currently suggests that obesity risk may be lower when ASBs replace SSBs in the diet. Still, additional evidence from experimental studies is needed to more definitively determine the benefits and risks of frequent ASB consumption. (C) 2013 International Life Sciences Institute
引用
收藏
页码:433 / 440
页数:8
相关论文
共 50 条
  • [21] Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity A Comprehensive Review
    Mozaffarian, Dariush
    CIRCULATION, 2016, 133 (02) : 187 - 225
  • [22] Prevention of Diabetes and Cardiovascular Disease in Obesity
    La Sala, Lucia
    Pontiroli, Antonio E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 17
  • [23] Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence
    Al-Sofiani, Mohammed E.
    Derenbecker, Robert
    Quartuccio, Michael
    Kalyani, Rita R.
    CURRENT DIABETES REPORTS, 2019, 19 (10)
  • [24] Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence
    Mohammed E. Al-Sofiani
    Robert Derenbecker
    Michael Quartuccio
    Rita R. Kalyani
    Current Diabetes Reports, 2019, 19
  • [25] Preliminary evidence of glycine as a biomarker of cardiovascular disease risk in children with obesity
    do Prado, Wagner Luiz
    Josephson, Samantha
    Cosentino, Ralph G.
    Churilla, James R.
    Hossain, Jobayer
    Balagopal, P. Babu
    INTERNATIONAL JOURNAL OF OBESITY, 2023, 47 (10) : 1023 - 1026
  • [26] Preliminary evidence of glycine as a biomarker of cardiovascular disease risk in children with obesity
    Wagner Luiz do Prado
    Samantha Josephson
    Ralph G. Cosentino
    James R. Churilla
    Jobayer Hossain
    P. Babu Balagopal
    International Journal of Obesity, 2023, 47 : 1023 - 1026
  • [27] Alcoholic beverages, obesity, physical activity and other nutritional factors, and cancer risk: A review of the evidence
    Latino-Martel, Paule
    Cottet, Vanessa
    Druesne-Pecollo, Nathalie
    Pierre, Fabrice H. F.
    Touillaud, Marina
    Touvier, Mathilde
    Vasson, Marie-Paule
    Deschasaux, Melanie
    Le Merdy, Julie
    Barrandon, Emilie
    Ancellin, Raphaelle
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 99 : 308 - 323
  • [28] Cardiovascular endocrinology 2 - Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents
    Goran, MI
    Ball, GDC
    Cruz, ML
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04): : 1417 - 1427
  • [29] Effect of Mediterranean diet in diabetes control and cardiovascular risk modification: a systematic review
    Sleiman, Dana
    Al-Badri, Marwa R.
    Azar, Sami T.
    FRONTIERS IN PUBLIC HEALTH, 2015, 3
  • [30] JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk
    Wyne, Kathleen L.
    Litwin, Sheldon E.
    Cusi, Kenneth
    Guyton, John R.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (02) : 115 - 127